|
Re: Positives & negatives
|
7
|
Resverlogix Corp.
|
Sep 15, 2015 12:23PM
|
|
Re: Orphan Disease Announcement
|
7
|
Resverlogix Corp.
|
Sep 24, 2015 06:41PM
|
|
Re: Orphan Disease Announcement
|
2
|
Resverlogix Corp.
|
Sep 24, 2015 08:13PM
|
|
Re: PNH
|
2
|
Resverlogix Corp.
|
Sep 24, 2015 10:01PM
|
|
Re: Orphan Disease Program
|
5
|
Resverlogix Corp.
|
Sep 25, 2015 02:09PM
|
|
Re: Orphan Disease Program
|
8
|
Resverlogix Corp.
|
Sep 25, 2015 03:10PM
|
|
Re: ...is anybody out there at the AGM...?
|
15
|
Resverlogix Corp.
|
Sep 30, 2015 04:02PM
|
|
Re: ...is anybody out there at the AGM...?
|
6
|
Resverlogix Corp.
|
Sep 30, 2015 04:57PM
|
|
Re: ...is anybody out there at the AGM...?
|
7
|
Resverlogix Corp.
|
Sep 30, 2015 05:04PM
|
|
A few thoughts
|
13
|
Resverlogix Corp.
|
Oct 01, 2015 06:09PM
|
|
Re: Share price performance in context
|
16
|
Resverlogix Corp.
|
Oct 02, 2015 10:17AM
|
|
Re: Explanation of difference between Endcrinology and CVD
|
10
|
Resverlogix Corp.
|
Oct 05, 2015 12:24PM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
6
|
Resverlogix Corp.
|
Oct 12, 2015 04:22PM
|
|
Re: After the dust settles in 3 weeks
|
4
|
Resverlogix Corp.
|
Oct 22, 2015 04:46PM
|
|
Re: Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone
|
6
|
Resverlogix Corp.
|
Oct 26, 2015 02:16PM
|
|
Re: Stonegate Report
|
5
|
Resverlogix Corp.
|
Nov 06, 2015 07:08PM
|
|
Re: Resverlogix Commences Dosing in Phase 3 Clinical Trial BETonMACE
|
7
|
Resverlogix Corp.
|
Nov 12, 2015 12:54PM
|
|
Re: Outlook
|
7
|
Resverlogix Corp.
|
Nov 16, 2015 02:34PM
|
|
Re: Outlook
|
2
|
Resverlogix Corp.
|
Nov 16, 2015 04:41PM
|
|
Re: Stability
|
9
|
Resverlogix Corp.
|
Nov 23, 2015 02:21PM
|
